HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Capsugel

www.capsugel.com

Latest From Capsugel

Strides’ Founder Considering Stake Sale In UK CDMO?

More M&A may be in store in the contract development and manufacturing space, with the founder of India’s Strides group apparently open to divesting his holding in the UK-based Sterling Pharma Solutions, at least going by what some deal street insiders say.

M & A India

Sturman Leads Nature's Bounty For New Owner: Health And Wellness Industry News

Consumer health product industry veteran executive Paul Sturman takes the helm at Nature's Bounty Co. on the day that private equity firm Kohlberg Kravis Roberts & Co. LP closed its acquisition of a controlling interest in the nutritional and health and wellness product manufacturer from Carlyle Group LP. The Ronkonkoma, N.Y.-based firm on Sept. 28 said Sturman has more than 30 years of experience in the sector, including leading Pfizer Inc.'s consumer product group and is a past chairman of the Consumer Healthcare Products Association. (Also see "KKR Steers Nature's Bounty With Carlyle In Back Seat After Seven-Year Ride" - HBW Insight, 24 Jul, 2017.) Sturman succeeds Steve Cahillane, the second CEO Carlyle appointed in 2014 after acquiring Nature's Bounty, then NBTY Inc., in 2010 and taking the firm private. (Also see "Carlyle Group Gives NBTY Helm To Former Coca-Cola Executive Cahillane" - Pink Sheet, 20 Aug, 2014.)

Dietary Supplements Advertising, Marketing & Sales

KKR Steers Nature's Bounty With Carlyle In Back Seat After Seven-Year Ride

Since acquiring Nature's Bounty in 2010 and taking the publicly traded firm private, Carlyle could have been at the helm longer than executives at the private equity firm intended or expected, exceeding the five-year plan typical for similar investments.

Dietary Supplements M & A

New Parent Lonza Welcomes Capsugel's Independent Streak To Innovate

Lonza acquires Capsugel for $5.5bn cash, nearly twice as much as private equity firm KKR paid Pfizer for it, to enhance its product development and expand the market for its contract development and manufacturing services for drug and nutritional products.

United States Switzerland
See All

Company Information

  • Industry
  • Biotechnology
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
    • Drug Delivery
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Capsugel
  • Senior Management
  • Guido Driesen, Pres. & CEO
    John Shroyer , SVP & CFO
    Keith Hutchison, PhD, VP, R&D
    John Cullivan , SVP, Corp. Bus. Dev. & Strategy
    Serge Enokian, SVP, Sales
    Erasmo Schutzer , SVP, Chief Mktg. Officer
    Anthony Macci , SVP, Global Operations
  • Contact Info
  • Capsugel
    Phone: (862) 242-1700
    412 Mt. Kemble Ave.,
    Ste. 200C
    Morristown, NJ 07960
    USA
UsernamePublicRestriction

Register